It was reported that in-stent restenosis and ischemia occurred, requiring intervention.On (b)(6) 2023, this 6x40, 130 cm eluvia drug-eluting vascular stent system was selected for use in an atherectomy and balloon angioplasty of the right superficial femoral artery (sfa) and popliteal artery, and stenting of the right sfa.Atherectomy was performed to debulk the in-stent restenosis of an unknown stent.Repeat imaging showed persistent residual stenosis; therefore, this stent was deployed at the proximal end of the existing stent, overlapping approximately 5 mm.Balloon angioplasty was then performed to the distal sfa and above-knee popliteal with a 5 x 200 mm balloon inflated for 3 minutes.Final imaging showed an excellent result with no significant residual stenosis, brisk flow and preserved runoff.On (b)(6) 2024, selective right lower extremity arteriogram, atherectomy, balloon angioplasty of the right sfa, percutaneous mechanical thrombectomy of the right popliteal artery, and intravascular ultrasound were performed due to peripheral artery disease with acute limb threatening ischemia.Imaging showed the proximal sfa was patent; however, the two overlapping stents were occluded from the distal sfa to the above knee popliteal artery.There appeared to be chronic atherosclerotic stenosis in the sfa just proximal to the stent.The sfa was occluded at the origin of the stent.Atherectomy was performed of the sfa lesion and mechanical thrombectomy of the thrombosed popliteal stent from the distal sfa to the above knee popliteal.Repeat imaging showed a patent flow lumen with some irregularity; therefore, angioplasty was performed with a drug coated balloon.Repeat imaging showed a good result in the sfa and popliteal.No patient complications were reported.
|